Compounds > phenylalanine

phenylalanine and Complications of Diabetes Mellitus

phenylalanine has been researched along with Complications of Diabetes Mellitus in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19901 (14.29)18.7374
1990's0 (0.00)18.2507
2000's4 (57.14)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adachi, T; Fukase, K; Ito, J; Katagiri, T; Kitagawa, M; Ohta, I; Yamanaka, Y1
Kataoka, Y; Kimura, K; Kosuge, M; Miyamoto, Y; Miyazaki, S; Sase, K; Yasuda, S; Yoshimasa, Y1
Yamada, K1
Ferriman, A1
Ishida, H; Kadowaki, T; Kawamori, R1
Gall, MA; Lammert, M; Minshall, ME; Nicklasson, L; Palmer, AJ; Roze, S; Spinas, GA; Valentine, WJ1
Tronnier, H1

Reviews

1 review(s) available for phenylalanine and Complications of Diabetes Mellitus

ArticleYear
[Pharmacological treatment of postprandial hyperglycemia in hypertensive patients with type 2 diabetes mellitus].
    Nihon rinsho. Japanese journal of clinical medicine, 2003, Volume: 61, Issue:7

    Topics: Acarbose; Cyclohexanes; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Glycoside Hydrolase Inhibitors; Humans; Hyperglycemia; Hypertension; Hypoglycemic Agents; Inositol; Insulin Resistance; Nateglinide; Obesity; Phenylalanine; Postprandial Period

2003

Trials

1 trial(s) available for phenylalanine and Complications of Diabetes Mellitus

ArticleYear
Effects of voglibose and nateglinide on glycemic status and coronary atherosclerosis in early-stage diabetic patients.
    Circulation journal : official journal of the Japanese Circulation Society, 2012, Volume: 76, Issue:3

    Topics: Aged; Coronary Artery Disease; Cyclohexanes; Diabetes Complications; Diabetes Mellitus; Female; Glycemic Index; Humans; Hypoglycemic Agents; Inositol; Male; Middle Aged; Nateglinide; Phenylalanine

2012

Other Studies

5 other study(ies) available for phenylalanine and Complications of Diabetes Mellitus

ArticleYear
Diabetic Hemichorea-hemiballism after Prompt Improvement in Hyperglycemia.
    Internal medicine (Tokyo, Japan), 2017, Nov-15, Volume: 56, Issue:22

    Topics: Chorea; Cyclohexanes; Diabetes Complications; Dyskinesias; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemic Agents; Linagliptin; Lower Extremity; Magnetic Resonance Imaging; Male; Middle Aged; Nateglinide; Phenylalanine

2017
Novartis breached code after doctors say it "invented" a disease.
    BMJ (Clinical research ed.), 2002, Dec-14, Volume: 325, Issue:7377

    Topics: Advertising; Blood Glucose; Cyclohexanes; Diabetes Complications; Diabetes Mellitus; Disclosure; Drug Industry; Europe; Family Practice; Humans; Hyperglycemia; Hypoglycemic Agents; Meta-Analysis as Topic; Nateglinide; Phenylalanine; Prospective Studies; Risk; United Kingdom

2002
[Achieving better control of blood sugar--understanding of oral hypoglycemic agents according to their characteristics in pharmacological action mechanism (discussion)].
    Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62, Issue:4

    Topics: Administration, Oral; Cardiovascular Diseases; Cyclohexanes; Diabetes Complications; Diabetes Mellitus; Drug Therapy, Combination; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemia; Hypoglycemic Agents; Indoles; Inositol; Insulin; Insulin Resistance; Insulin Secretion; Isoindoles; Nateglinide; Phenylalanine; Risk Factors; Stimulation, Chemical; Sulfonylurea Compounds; Thiazolidinediones

2004
Comparing the long-term cost-effectiveness of repaglinide plus metformin versus nateglinide plus metformin in type 2 diabetes patients with inadequate glycaemic control: an application of the CORE Diabetes Model in type 2 diabetes.
    Current medical research and opinion, 2004, Volume: 20 Suppl 1

    Topics: Carbamates; Cohort Studies; Computer Simulation; Cost of Illness; Cost-Benefit Analysis; Cyclohexanes; Decision Support Systems, Clinical; Diabetes Complications; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glycated Hemoglobin; Health Care Costs; Humans; Male; Metformin; Middle Aged; Models, Econometric; Nateglinide; Outcome Assessment, Health Care; Phenylalanine; Piperidines; Quality-Adjusted Life Years

2004
[Diagnosis and therapy of the secondary disease: dermatology].
    International journal of clinical pharmacology, therapy and toxicology, 1973, Volume: 8, Issue:4

    Topics: Candidiasis; Diabetes Complications; Female; Herpes Zoster; Humans; Liver Diseases; Malabsorption Syndromes; Male; Parathyroid Diseases; Phenylalanine; Pigmentation Disorders; Skin Diseases; Skin Manifestations; Tryptophan; Tyrosine; Vitamin B 12 Deficiency

1973